Lectin-Based Fluorescent Comparison of Glycan Profile—FDA Validation to Expedite Approval of Biosimilars
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25179240 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sarfaraz K Niazi und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, University of Illinois, Chicago, IL 60612, USA. Hauptthemen laut MEDLINE: Biosimilar Pharmaceuticals, Lectins, Polysaccharides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glycan profile comparisons are one of the most tedious analytical exercises for establishing compliance with recombinant therapeutic protein batches. Based on its intensive research, the FDA has confirmed that lectin array binding with fluorescent monitoring is the fastest and most reliable method for profile comparisons. Using a database of over 150 biological products expressed in nine diverse mammalian cell systems, the FDA immobilized 74 lectins to study their binding using fluorescently labeled glycoproteins. The FDA identified nine distinct lectins from a custom-designed lectin microarray: rPhoSL, rOTH3, RCA120, rMan2, MAL_I, rPSL1a, PHAE, rMOA, and PHALs, which detect core fucose, terminal GlcNAc, terminal β-galactose, high mannose, α-2,3-linked sialic acids, α-2,6-linked sialic acids, bisecting GlcNAc, terminal α-galactose, and triantennary structures, respectively. This method can be used for screening and routine testing and to monitor batch-to-batch variability of therapeutic proteins, including establishing analytical similarity as a crucial part of biosimilar development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, University of Illinois, Chicago, IL 60612, USA.
- Faculty of Pharmaceutical Sciences, University of Iceland, IS-107 Reykjavik, Iceland.
ORCID-Profile: Sarfaraz K Niazi
Zitieren
APA
Niazi, S. K., & Omarsdottir, S. (2024). Lectin-Based Fluorescent Comparison of Glycan Profile—FDA Validation to Expedite Approval of Biosimilars. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179240
Vancouver
Niazi SK, Omarsdottir S. Lectin-Based Fluorescent Comparison of Glycan Profile—FDA Validation to Expedite Approval of Biosimilars. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179240
BibTeX
@article{Niazi2024,
author = {Niazi, Sarfaraz K and Omarsdottir, Sesselja},
title = {Lectin-Based Fluorescent Comparison of Glycan Profile—FDA Validation to Expedite Approval of Biosimilars},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25179240}
}
EUVIMED